Journal of the International AIDS Society

Article	Citations
Shifts in UNAIDS ethics guidance and implications for ethics review of preventive HIV vaccine trials	97
	96
	71
Incorporating a trauma‐informed perspective in HIV‐related research with transgender and gender diverse individuals	57
	54
Assessing intrinsic capacity for person‐centred HIV care: a cross‐sectional study in ageing populations in Malaysia and Hong Kong	52
Sustaining the HIV/AIDS response: PEPFAR's vision	50
An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States	49
Telehealth effectiveness for pre‐exposure prophylaxis delivery in Brazilian public services: the Combine! Study	47
Issue Information	45
Reports from the front lines: Field Notes, a new JIAS feature	40
The fight for bodily agency, human rights and lived experiences of LGBTIQ+ persons should be celebrated every day	39
	38
	38
Food insecurity and frailty among women with and without HIV in the United States: a cross‐sectional analysis	38
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies	37
Combination HIV prevention during pregnancy and the post‐partum period in Malawi and Zambia: a mathematical modelling analysis	36
Non‐clinical considerations for supporting accelerated inclusion of pregnant women in pre‐licensure clinical trials with anti‐HIV agents	34
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken	34
What will it take to get to the heart of stigma in the context of HIV?	32
	32
Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Eval	32
Health‐related quality of life of female sex workers living with HIV in South Africa: a cross‐sectional study	31
	31
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study	31

AUTHOR INDEX	31
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies	30
Mitigation strategies to safely conduct HIV treatment research in the context of COVID‐19	30
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)	30
Response to “On the risk of using raw regional data on new HIV infections in France” by Tassi et al.	29
Tobacco smoking, smoking cessation and life expectancy among people with HIV on antiretroviral therapy in South Africa: a simulation modelling study	29
Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted review	28
Ensuring access to justice: the need for community paralegals to end AIDS by 2030	28
	27
Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care	27
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review	27
Abstract Supplement Abstracts from IAS 2023, the 12th IAS Conference on HIV Science, 23 – 26 July, Brisbane, Australia & Virtual	26
	26
HIV pre‐exposure prophylaxis programme preferences among sexually active HIV‐negative transgender and gender diverse adults in the United States: a conjoint analysis	26
Advancing Programme Science approaches to understand gaps in HIV prevention programme coverage for key populations in 12 Nigerian states: findings from the 2020 Integrated Biological and Behavioural S	26
Promoting STI self‐testing through HIV self‐testing	25
AUTHOR INDEX	25
Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa	25
Same‐day test and treat for infants with HIV infection: finally within reach	25
The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub‐Saharan Africa: a scoping review	25
The ethics of exclusion: why pregnant and lactating women must be front and centre of HIV research	25
HIV self‐testing partially filled the HIV testing gap among men who have sex with men in China during the COVID‐19 pandemic: results from an online survey	24
Setting the research agenda: involving parents in research on children who are HIV‐free	24
Progress towards 2020 global HIV impact and treatment targets	24
	23
Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study	23
When and how to intervene to improve the health of children born HIV‐free	23
Validation of population‐level HIV‐1 incidence estimation by cross‐sectional incidence assays in the HPTN 071 (PopART) trial	23
Issue Information	23
It is a question of equity: time to talk about children who are HIV‐exposed and “HIV‐free”	23
High retention among key populations initiated on HIV pre‐exposure prophylaxis in Kigali City, Rwanda	22
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual	22
Reducing stigma and promoting HIV wellness/mental health of sexual and gender minorities: RCT results from a group‐based programme in Nigeria	22
A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya	22
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub‐study of the ODYSSEY randomized controlled trial	22
Individual health behaviours to combat the COVID‐19 pandemic: lessons from HIV socio‐behavioural science	21
Prevalence of cardiovascular risk factors by HIV status in a population‐based cohort in South Central Uganda: a cross‐sectional survey	21
Being yourself is a defect: analysis of documented rights violations related to sexual orientation, gender identity and HIV in 2022 using the REAct system in six eastern European, Caucasus and Central	21
Current allocations and target apportionment for HIV testing and treatment services for marginalized populations: characterizing PEPFAR investment and strategy	21
The longitudinal association between depression, anxiety symptoms and HIV outcomes, and the modifying effect of alcohol dependence among ART clients with hazardous alcohol use in Vietnam	21
Same‐day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort study	21
PrEP user profiles, dynamics of PrEP use and follow‐up: a cohort analysis at a Belgian HIV centre (2017–2020)	20
Clinical outcomes and risk factors for immune recovery and all‐cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study	20
Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis	20
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States	20
Occupational post‐exposure prophylaxis among healthcare workers: a scoping review of factors affecting optimal utilization	20
Improving ART initiation among men who use HIV self‐testing in Malawi: a qualitative study	20
Prevalence and co‐occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low‐ and middle‐income countries: a cross‐sectional study	19
The effect of tracer contact on return to care among adult, “lost to follow‐up” patients living with HIV in Zambia: an instrumental variable analysis	19
Strengthening the evidence to improve health outcomes of children with perinatal HIV exposure	19

HIV PrEP is more than ART‐lite: Longitudinal study of real‐world PrEP services data identifies missing measures meaningful to HIV prevention programming	18
Transactional sex among adolescent girls and young women enrolled in a cash plus intervention in rural Tanzania: a mixed‐methods study	18
Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta‐analysis	18
Factors that influence adolescent girls and young women's re‐initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa	17
Early impacts of the PEPFAR stop‐work order: a rapid assessment	17
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort	17
Estimating the epidemic consequences of HIV prevention gaps among key populations	17
“It's a burden, it's a nuisance. I wish I didn't have these other ailments”: a qualitative exploration of comorbidities management among older people living with HIV who use drugs in Vancouver, Britis	17
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit	16
Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study	16
A trial of nurturing care among children who are HIV‐exposed and uninfected in eSwatini	16
Mobility and HIV care engagement: a research agenda	16
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women	16
Does resource insecurity drive HIV‐related stigma? Associations between food and housing insecurity with HIV‐related stigma in cohort of women living with HIV in Canada	16
Measuring the performance of HIV self‐testing at private pharmacies in Kenya: a cross‐sectional study	16
Priorities for health and wellbeing for older people with and without HIV in Uganda: a qualitative methods study	16
Mobility and ART retention among men in Malawi: a mixed‐methods study	16
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa	16
Imperfect adherence in real life: a prevention‐effective perspective on adherence to daily and event‐driven HIV pre‐exposure prophylaxis among men who have sex with men – a prospective cohort study in	15
Partner testing with HIV self‐test distribution by Ugandan pregnant women living with HIV: a randomized trial	15
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study	15
Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z‐CHECK project, 2019–2020	15
“I felt special!”: a qualitative study of peer‐delivered HIV self‐tests, STI self‐sampling kits and PrEP for transgender women in Uganda	15
HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs	15
Intervening for HIV prevention and mental health: a review of global literature	14
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework	14
Investigating the effectiveness of web‐based HIV self‐test distribution and linkage to HIV treatment and PrEP among groups at elevated risk of HIV in Viet Nam provinces: a mixed‐methods analysis of im	14
What will it take to bring LAED medication regimens to young people?	14
Provider perspectives on service delivery modifications to maintain access to HIV pre‐exposure prophylaxis during the COVID‐19 pandemic: qualitative results from a PrEP implementation project in Kenya	14
Cross‐sectional trends in HIV prevalence among pregnant women in Botswana: an opportunity for PrEP?	14
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study	14
Providing HIV‐assisted partner services to partners of partners in western Kenya: an implementation science study	14
Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial	14
Frameworks and measures for HIV‐related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review	14
Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice	14
Uptake of Primary Care Services and HIV and Syphilis Infection among Transgender Women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016 – 2019	14
Integrating a mental health intervention into PrEP services for South African young women: a human‐centred implementation research approach to intervention development	14
AUTHOR INDEX	14
An observational cohort study evaluating PrEP reach, engagement and persistence through a community‐based mobile clinic in Miami‐Dade County, Florida	14
	13
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers	13
Integrating hepatitis C testing and treatment into routine HIV care in Cameroon is feasible	13
Socio‐economic status and adherence to HIV preventive and therapeutic interventions: exploring the mediating role of food insecurity among men who have sex with men and transgender and non‐binary pers	13
The importance of partnerships in accelerating HIV vaccine research and development	13
AUTHOR INDEX	13
Knowledge as resistance: advancing global health in challenging times	13
There is no path to ending AIDS by 2030 without improving human rights	13
	13
The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study	13
Issue Information	13
	13
	12
Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis	12
Comparative costs and potential affordability of a multifaceted intervention to improve treatment outcomes among people with HIV who inject drugs in Russia: economic evaluation of the LINC‐II randomiz	12
Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV	12
Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaborati	12
	12
Using community conversations to integrate violence screening and referrals into HIV care for young women living with HIV in Lusaka, Zambia	12
Ten‐year attrition and antiretroviral therapy response among HIV‐positive adults: a sex‐based cohort analysis from eight West African countries	12
Treatment‐naïve people living with HIV aged 50 years or older in Beijing, China, 2010–2020: joinpoint regression model analysis of surveillance data	12
Persistently high HIV incidence among men who have sex with men and people who inject drugs attending integrated care centres in India: a longitudinal assessment of clinic‐based data	12
The impact of free antiretroviral therapy for pregnant non‐citizens and their infants in Botswana	12
Social and structural drivers of HIV vulnerability among a respondent‐driven sample of feminine and non‐feminine presenting transgender women who have sex with men in Zimbabwe	12
How community ART delivery may improve HIV treatment outcomes: Qualitative inquiry into mechanisms of effect in a randomized trial of community‐based ART initiation, monitoring and re‐supply (DO ART)	12
Clinical outcomes after extended 12‐month antiretroviral therapy prescriptions in a community‐based differentiated HIV service delivery programme in South Africa: a retrospective cohort study	11
Failing to learn the lessons: the U.S. response on global health security ignores 20 years of PEPFAR	11
A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females	11
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster‐randomized	11
Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis	11
Patient and provider perceptions of a community‐based accompaniment intervention for adolescents transitioning to adult HIV care in urban Peru: a qualitative analysis	11
HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia‐Pacific region: a longitudinal cohort study	11
Adherence measurement considerations for oral antiretroviral medications	11
Adaora A. Adimora, in memoriam	11
HIV service delivery in the time of COVID‐19: focus group discussions with key populations in India	11
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review	11
Closing the gap: did delivery approaches complementary to home‐based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?	11
High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort	11
Patterns of person‐centred communications in public HIV clinics: a latent class analysis using the Roter interaction analysis system	11
Prevalence and factors associated with common mental disorders in young people living with HIV in sub‐Saharan Africa: a systematic review	11
	10

Preferences for transitional HIV care among people living with HIV recently released from prison in Zambia: a discrete choice experiment	10
Improving retention in antenatal and postnatal care: a systematic review of evidence to inform strategies for adolescents and young women living with HIV	10
Author Index	10
Annual home‐based HIV testing in the Chókwè Health Demographic Surveillance System, Mozambique, 2014 to 2019: serial population‐based survey evaluation	10
Issue Information	10
PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand	10
	10
An investment case: the role of advocacy in addressing discrimination of vulnerable and marginalized populations at risk for HIV in sub‐Saharan Africa	10
	10
	10
HIV‐1 proviral landscape characterization varies by pipeline analysis	10
	10
Fortieth anniversary reflections on the early days of HIV and the current era	10
Choosing event‐driven and daily HIV pre‐exposure prophylaxis – data from two European PrEP demonstration projects among men who have sex with men	9
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan	9
Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemics	9
AUTHOR INDEX	9
AUTHOR INDEX	9
Issue Information	9
Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa	9
Getting back on track to ending AIDS in children: it could just be easier than you think	9
Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda	9
Implementing a male‐specific ART counselling curriculum: a quality assessment with healthcare workers in Malawi	9
	9
The power of one – in memoriam of Paul E. Farmer	9
India's adaptation of HIV services to ensure continuity of service delivery during the COVID‐19 pandemic	9
Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection	9
HIV vaccines beyond COVID‐19: merits of trust	9
Impact and cost‐effectiveness of the national scale‐up of HIV pre‐exposure prophylaxis among female sex workers in South Africa: a modelling analysis	9
Refining global HIV estimates for decision‐making: advances in analytic and modelling methods used by the Joint United Nations Programme on HIV/AIDS	9
Estimating male circumcision coverage in 15 priority countries in sub‐Saharan Africa	9
Issue Information	9
Strengthening HIV and HIV co‐morbidity care in low‐ and middle‐income countries: insights from behavioural economics to improve healthcare worker behaviour	9
Correction to “Updated guidelines on HIV post‐exposure prophylaxis: continued efforts towards increased accessibility”	9
A multi‐country cross‐sectional study to assess predictors of daily versus on‐demand oral pre‐exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe	9
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States	9
A transformed global enterprise for an HIV vaccine	9
Programme Science in PEPFAR: a pathway to a sustainable HIV response	8
Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and	8
Differentiating the incidence and burden of HIV by age among women who sell sex: a systematic review and meta‐analysis	8
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment	8
Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub‐Saharan Africa	8
Managers’ and providers’ perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study	8
When healthcare providers are supportive, ‘I'd rather not test alone’: Exploring uptake and acceptability of HIV self‐testing for youth in Zimbabwe – A mixed method study	8
Pregnancy and medicines: time for paradigm change	8
Leveraging HIV self‐testing to achieve the UNAIDS 2025 targets in the South and Southeast Asia region	8
Association of demographics, HCV co‐infection, HIV‐1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV‐1 Surveillance Network	8
Treating depression and improving adherence in HIV care with task‐shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial	8
The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub‐Saharan Africa	8
	8
A thank you note to our peer reviewers (2023)	8
Adolescent and young adult preferences for financial incentives to support adherence to antiretroviral therapy in Kenya: a mixed methods study	8
Using a Programme Science approach to substantially reduce the risk of HIV transmission and acquisition in sex transactions among female sex workers in Zimbabwe	8
Response: “Cost‐effectiveness and budget impact analysis of the implementation of differentiated service delivery models for HIV treatment in Mozambique: a modelling study”: resource reductions are no	8
The AIDS pandemic in the 2020s: community responses bring female underserved populations into sharper focus	8
Including transgender populations in mathematical models for HIV treatment and prevention: current barriers and policy implications	8
Person‐centred, integrated non‐communicable disease and HIV decentralized drug distribution in Eswatini and South Africa: outcomes and challenges	8
Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta‐analysis	8
Real‐world use and outcomes of dolutegravir‐containing antiretroviral therapy in HIV and tuberculosis co‐infection: a site survey and cohort study in sub‐Saharan Africa	8
	8